0001437749-21-009758.txt : 20210426 0001437749-21-009758.hdr.sgml : 20210426 20210426083215 ACCESSION NUMBER: 0001437749-21-009758 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarrabain Alex CENTRAL INDEX KEY: 0001736937 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21851663 MAIL ADDRESS: STREET 1: 18908 89 AVENUE CITY: EDMONTON STATE: A0 ZIP: T5T 6B7 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5 1 rdgdoc.xml FORM 5 X0306 5 2017-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 7405 TECUMSEH ROAD EAST SUITE 300 WINDSOR, ONTARIO, CANADA A6 N8T 1G2 ONTARIO, CANADA 1 1 Chief Financial Officer* Common Stock 2017-11-30 4 A 0 L 20000 0 A 69942 D 20,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. * On July 12, 2017, Alex Tarrabain (the "Reporting Person") was appointed as a director of the issuer. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the issuer. /s/ Alex Tarrabain 2021-04-26